Fifteen-minute consultation: When medicines don't work-the child with poorly controlled seizures

Pooja Harijan1,2, Arnab Kumar Seal3, Manish Prasad4

  • 1Department of Paediatrics, Peterborough City Hospital, North West Anglia NHS Foundation Trust, Peterborough, UK.

Insights

Drug-resistant epilepsy (DRE) affects 20%-30% of pediatric epilepsy cases. Recent advancements in epilepsy surgery and multimodal evaluations have improved DRE management, with an algorithmic approach presented for affected children.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Drug-resistant epilepsy (DRE) impacts 20%-30% of children with epilepsy.
  • DRE significantly affects pediatric patients' quality of life.

Purpose of the Study:

  • To review current evidence and expert opinion on managing DRE in children.
  • To present an algorithmic approach for diagnosing and managing pediatric DRE.

Main Methods:

  • Review of recent evidence and published opinions on DRE management in pediatric populations.
  • Development of a structured algorithmic approach for DRE evaluation.

Main Results:

  • Management strategies for pediatric DRE have advanced with streamlined epilepsy surgery services.
  • Quaternary multimodal evaluations are integral to current DRE management.

Conclusions:

  • Improved management protocols and surgical services offer better outcomes for children with DRE.
  • An algorithmic approach can guide clinicians in evaluating and treating pediatric DRE.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...